Table 1.
Characteristics | Number of participants (n = 80,837) |
---|---|
Age in year, mean (± SD) | 46.13 (± 14.21) |
18-59 years old, N (%) | 64,807 (80.17%) |
>= 60 years old, N (%) | 16,030 (19.83%) |
Gender, N women (%) | 55,352 (68.50%) |
Total participants with CYP2D6/2C19/2C9 mediated DDI, N(%) | 1,125 (1.40%) |
Total participants overlapped with IADB.nl database, N (%) | 25,387 (31.41%) |
|
45.54 (± 14.62) |
|
20,277 (79.90%) |
|
5,110 (20.10%) |
|
17,416 (68.60%) |
|
366 (1.44%) |
SD, Standard Deviation; DDI, drug-drug interaction.